Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative
AssigneeCell Pathways, Inc.
InventorsRifat Pamukcu, Joseph M. Lobacki
Life of this patent
Estimating the term…
Abstract
This invention provides a method for treating a patient with neoplasia by an adjuvant therapy that includes treatment with an antineoplastic vinca alkaloid derivative.
Claims17
A composition comprising a vinca alkaloid derivative and an inhibitor of a cGMP specific phosphodiesterase inhibitor for use as a medicament.
A method of inhibiting the growth of neoplastic lesions in a patient comprising administering to the patient a vinca alkaloid derivative and a cGMP-specific phosphodiesterase inhibitor.
A kit comprising a vinca alkaloid derivative and an inhibitor of a cGMP-specific phosphodiesterase for simultaneous or sequential administration to a patient to treat neoplastic lesions.
A packaged pharmaceutical composition for the treatment of neoplasia, comprising:
- (a) a pharmaceutical composition containing a pharmaceutically acceptable carrier and a vinca alkaloid derivative;
- (b) written material describing said compound and providing directions for use with an anti-neoplastic cGMP PDE inhibitor;
- and
- (c) packaging for carrying said pharmaceutical composition and said written material.
A packaged pharmaceutical composition for the treatment of neoplasia, comprising:
- (a) a pharmaceutical composition containing a pharmaceutically acceptable carrier and an anti-neoplastic cGMP PDE inhibitor;
- (b) written material describing said compound and providing directions for use with an a vinca alkaloid derivative;
- and
- (c) packaging for carrying said pharmaceutical composition and said written material.
Dependencies are inferred from the claim text.